Kimyrsa (oritavancin diphosphate)

**Product type:** Human Prescription Drug

**Active ingredient:** ORITAVANCIN DIPHOSPHATE

**Strength:** 1200 mg/40mL

**Dosage form:** Injection, Powder, Lyophilized, For Solution

**Route:** Intravenous

**Labeler:** Melinta Therapeutics, LLC

**Marketing category:** NDA (NDA214155)

**Pharmacologic class:** Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS]